That was my understanding, Q4....and hence my expectations/hopes for a nice Christmas present.

But assuming we are heading somewhere around $10 per share by the end of the year, or higher....I highly doubt its something that would happen in just a few days, or even in a few weeks.  If we could get some financing news even now I think we could easily see a pop, maybe to north of $3 or $4, it happens with biotech all the time.

The only thing that would send us for a big and sudden pop imo would be a buyout....but with the way things are structured vis a vis Hepa and Eastern, I don't think that's a realistic possibility.

If things do start happening I want to be on my toes, we've seen lots of big jumps here over the years....but they've never held.  I don't want to be kicking myself for bailing out for $3 or $5 when $10 or even $20+ could be in the cards though.  

April was nice in 2015....here's hoping 3 years is the magic number and that if it does happen, that this time we don't give it all back.